My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
MISSION VIEJO, CITY OF 1
Clerk
>
Contracts / Agreements
>
INACTIVE CONTRACTS (Originals Destroyed)
>
M-N (INACTIVE)
>
MISSION VIEJO, CITY OF 1
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
7/23/2015 9:19:37 AM
Creation date
7/26/2006 11:19:07 AM
Metadata
Fields
Template:
Contracts
Company Name
CITY OF MISSION VIEJO
Contract #
A-2005-310-20
Agency
Police
Council Approval Date
9/19/2005
Destruction Year
2012
Jump to thumbnail
< previous set
next set >
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
303
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
Attachment C <br />Section 9 Medical Supplies and Limited Tvpes of Pharmaceuticals <br />AEL Ref No Title/ Description Fall 2004 <br />SHSP/ LETPP MMRS EMPG SEL Ref Number <br />UASI <br />9.2.40 <br />Kit, Debridement, and Supplies 09MS- 01 -KOEB <br />C] ❑ <br />❑ <br />❑ <br />Single -use, disposable kit to clean soft tissue injuries and surfaces. <br />9.2.41 <br />Kit, Obstetrical 09MS- 01 -KTOB <br />❑N ❑ <br />❑ <br />[ J <br />Self- contained kit with supplies required to support obstetrical procedures. <br />9.2.42 <br />responsible for replenishing items after shelf -life expiration dates. <br />Kit, Thoracostomy and Supplies 09MS- 01 -THOR <br />E] ❑ <br />❑ <br />❑ <br />Self contained kit to perform and support chest decompression. <br />(9.3) Pharmaceuticals <br />9.3.0 <br />Pharmaceuticals <br />-v/' ❑ <br />❑ <br />❑ <br />Various pharmaceuticals required for response to a CBRNE terrorism <br />incident at the advanced life support level. Note that grantees are <br />responsible for replenishing items after shelf -life expiration dates. <br />9.3.1 <br />Adamantines <br />09PH -00 -ADAM <br />W] ❑ <br />❑ <br />❑ <br />Anti - viral; FDA approved to treat and prevent INFLUENZA A viruses. <br />Includes amantadine and rimantadine. Described in Federal Pandemic <br />Influenza Preparedness and Response Plan: <br />http://www.hhs.gov/nvpo/pandemicplan <br />Sample fact sheets available at: <br />htlp://www.niaid.nih.gov/facisheets/fludmgs.htm <br />http://hopkins-heic.org/infectious—diseases/influenzalfacts.htm <br />9.3.2 <br />Adenosine <br />09PH -00 -ADEN <br />Q ❑ <br />❑ <br />❑ <br />Anti- dysrhythmic <br />9.3.3 <br />Albuterol <br />09PH- 00 -ALBU <br />© ❑ <br />❑ <br />❑ <br />Bronchodilator <br />9.3.4 <br />Amiodarone <br />09PH- 00 -AMIO <br />❑d ❑ <br />❑ <br />❑ <br />Anti- dysrhythmic <br />9.3.5 <br />Amyl Nitrite <br />09PH- 00 -AMNI <br />[] ❑ <br />❑ <br />❑ <br />Vasodilator <br />9.3.6 <br />Antacids <br />09PH- 00 -ANTA <br />.] ❑ <br />❑ <br />❑ <br />Antacid <br />9.3.7 <br />Acetylsalicylic Acid <br />09PH- 00 -ASA <br />0 ❑ <br />❑ <br />❑ <br />Anticoagulant; analgesic, anti- inflammatory; fever reduction. <br />9.3.6 <br />Atropine Sulfate <br />09PH- 00 -ATSF <br />91 ❑ <br />❑ <br />❑ <br />Antidote for organophosphate and nerve agent exposure. <br />Interactive versions ofthis appendix and the Fall 2004 SEL are available on -line at tvrvtv.rkb.mipt. org. <br />Wednesday, April 27, 2005 Fall AEL: Page 49 of 78 <br />
The URL can be used to link to this page
Your browser does not support the video tag.